Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 804

1.

Mortality Benefits for Replacing Sitting Time with Different Physical Activities.

Matthews CE, Moore SC, Sampson J, Blair A, Xiao Q, Keadle SK, Hollenbeck A, Park Y.

Med Sci Sports Exerc. 2015 Jan 26. [Epub ahead of print]

PMID:
25628179
[PubMed - as supplied by publisher]
2.

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.

Johnson LA, Sanchez-Perez L, Suryadevara CM, Sampson JH.

Oncoimmunology. 2014 Jul 3;3(7):e944059. eCollection 2014.

PMID:
25610729
[PubMed]
3.

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.

Sanchez-Perez L, Suryadevara CM, Choi BD, Reap EA, Sampson JH.

Oncoimmunology. 2014 Jul 3;3(7):e944054. eCollection 2014.

PMID:
25610727
[PubMed]
4.

The Use of Joint Incentive Funding to Create a Department of Veterans Affairs-Department of Defense Vascular Surgery Program.

Noll RE Jr, Atkins BZ, Carson J, Sampson J, Dawson D, Hundahl S, Clouse WD.

JAMA Surg. 2015 Jan 21. doi: 10.1001/jamasurg.2014.1768. [Epub ahead of print] No abstract available.

PMID:
25608084
[PubMed - as supplied by publisher]
5.

An Assessment of Surgical and Anesthesia Staff at 10 Government Hospitals in Sierra Leone.

Vaughan E, Sesay F, Chima A, Mehes M, Lee B, Dordunoo D, Sitch A, de Wildt G, Kamara TB, Leigh B, Abdullah F, Sampson J.

JAMA Surg. 2015 Jan 21. doi: 10.1001/jamasurg.2014.2246. [Epub ahead of print]

PMID:
25607469
[PubMed - as supplied by publisher]
6.

Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: Implications for drug development.

Brown KE, Chagoya G, Kwatra SG, Yen T, Keir ST, Cooter M, Hoadley KA, Rasheed A, Lipp ES, Mclendon R, Ali-Osman F, Bigner DD, Sampson JH, Kwatra MM.

J Neurochem. 2015 Jan 17. doi: 10.1111/jnc.13032. [Epub ahead of print]

PMID:
25598002
[PubMed - as supplied by publisher]
7.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH.

Neuro Oncol. 2015 Jan 13. pii: nou348. [Epub ahead of print]

PMID:
25586468
[PubMed - as supplied by publisher]
8.

Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness.

Kmoch S, Majewski J, Ramamurthy V, Cao S, Fahiminiya S, Ren H, MacDonald IM, Lopez I, Sun V, Keser V, Khan A, Stránecký V, Hartmannová H, Přistoupilová A, Hodaňová K, Piherová L, Kuchař L, Baxová A, Chen R, Barsottini OG, Pyle A, Griffin H, Splitt M, Sallum J, Tolmie JL, Sampson JR, Chinnery P; Care4Rare Canada, Banin E, Sharon D, Dutta S, Grebler R, Helfrich-Foerster C, Pedroso JL, Kretzschmar D, Cayouette M, Koenekoop RK; Care4Rare Canada.

Nat Commun. 2015 Jan 9;6:5614. doi: 10.1038/ncomms6614.

PMID:
25574898
[PubMed - in process]
9.

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.

Sayour EJ, McLendon P, McLendon R, De Leon G, Reynolds R, Kresak J, Sampson JH, Mitchell DA.

Cancer Immunol Immunother. 2015 Jan 3. [Epub ahead of print]

PMID:
25555571
[PubMed - as supplied by publisher]
10.

LEVERAGING LOCAL IDENTITY-BY-DESCENT INCREASES THE POWER OF CASE/CONTROL GWAS WITH RELATED INDIVIDUALS.

Sampson JN, Wheeler B, Li P, Shi J.

Ann Appl Stat. 2014 Jun;8(2):974-998.

PMID:
25544865
[PubMed]
Free PMC Article
11.

IL-17A-Mediated Protection against Acanthamoeba Keratitis.

Suryawanshi A, Cao Z, Sampson JF, Panjwani N.

J Immunol. 2015 Jan 15;194(2):650-63. doi: 10.4049/jimmunol.1302707. Epub 2014 Dec 10.

PMID:
25505284
[PubMed - in process]
12.

Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.

Johnson CE, Hunt DK, Wiltshire M, Herbert TP, Sampson JR, Errington RJ, Davies DM, Tee AR.

Mol Oncol. 2014 Nov 22. pii: S1574-7891(14)00281-6. doi: 10.1016/j.molonc.2014.11.005. [Epub ahead of print]

PMID:
25498902
[PubMed - as supplied by publisher]
13.

Peptide vaccines for the treatment of glioblastoma.

Swartz AM, Batich KA, Fecci PE, Sampson JH.

J Neurooncol. 2014 Dec 10. [Epub ahead of print]

PMID:
25491947
[PubMed - as supplied by publisher]
14.

Defining the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases: Results of a Randomized Trial.

Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE 2nd, Allen KJ, Duffy E, Hoang JK, Chang Z, Yoo DS, Kelsey CR, Yin FF.

Int J Radiat Oncol Biol Phys. 2014 Oct 21. pii: S0360-3016(14)04088-7. doi: 10.1016/j.ijrobp.2014.09.004. [Epub ahead of print]

PMID:
25442342
[PubMed - as supplied by publisher]
15.

In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.

Jameson-Lee M, Koparde V, Griffith P, Scalora AF, Sampson JK, Khalid H, Sheth NU, Batalo M, Serrano MG, Roberts CH, Hess ML, Buck GA, Neale MC, Manjili MH, Toor AA.

Front Immunol. 2014 Nov 6;5:529. doi: 10.3389/fimmu.2014.00529. eCollection 2014. Review.

PMID:
25414699
[PubMed]
Free PMC Article
16.

Immunotherapy for primary brain tumors: no longer a matter of privilege.

Fecci PE, Heimberger AB, Sampson JH.

Clin Cancer Res. 2014 Nov 15;20(22):5620-9. doi: 10.1158/1078-0432.CCR-14-0832.

PMID:
25398845
[PubMed - in process]
17.

Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GMCSF and dose-intensified temozolomide.

Mitchell DA, Sayour EJ, Reap E, Schmittling RJ, De Leon G, Norberg P, Desjardins A, Friedman AH, Friedman HS, Archer GA, Sampson JH.

Cancer Immunol Res. 2014 Nov 11. pii: canimm.0100.2014. [Epub ahead of print]

PMID:
25387895
[PubMed - as supplied by publisher]
18.

Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.

Shiels MS, Gibson T, Sampson J, Albanes D, Andreotti G, Beane Freeman L, Berrington de Gonzalez A, Caporaso N, Curtis RE, Elena J, Freedman ND, Robien K, Black A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):3989-95. doi: 10.1200/JCO.2014.56.8220. Epub 2014 Nov 10.

PMID:
25385740
[PubMed - in process]
19.

Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.

Lin R, Chen L, Chen G, Hu C, Jiang S, Sevilla J, Wan Y, Sampson JH, Zhu B, Li QJ.

J Clin Invest. 2014 Dec 1;124(12):5352-67. doi: 10.1172/JCI76561. Epub 2014 Oct 27.

PMID:
25347474
[PubMed - in process]
20.

Epidermal growth factor receptor and variant III targeted immunotherapy.

Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH.

Neuro Oncol. 2014 Oct;16 Suppl 8:viii20-5. doi: 10.1093/neuonc/nou236.

PMID:
25342601
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk